Facebook
Twitter
Telegram
Report an ErrorBicycle Therapeutics plc Balance Sheet 2011-2024 | BCYC
Annual Balance Sheet Bicycle Therapeutics plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-491 M | -306 M | -406 M | -121 M | -90.2 M | -63.4 M | -67.7 M | - | - | - | - | - | - |
Long Term Debt |
30.7 M | 30.3 M | 29.9 M | 14.5 M | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
4.88 M | 3.12 M | 2.38 M | 844 K | 640 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 8.18 M | 143 M | 112 M | - | - | - | - | - | - |
Total Current Liabilities |
69.5 M | 53.3 M | 36.2 M | 23.1 M | 8.82 M | - | - | - | - | - | - | - | - |
Total Liabilities |
224 M | 140 M | 134 M | 65.7 M | 17 M | 151 M | 121 M | - | - | - | - | - | - |
Deferred Revenue |
25 M | 20.4 M | 19.3 M | 10.1 M | 728 K | 10 K | 3.98 M | - | - | - | - | - | - |
Retained Earnings |
-512 M | -331 M | -218 M | -152 M | -101 M | -69.9 M | -48.1 M | - | - | - | - | - | - |
Total Assets |
595 M | 411 M | 480 M | 161 M | 110 M | 81.6 M | 74 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
526 M | 339 M | 439 M | 136 M | - | 63.4 M | 67.7 M | - | - | - | - | - | - |
Book Value |
371 M | 271 M | 346 M | 95.5 M | 93.2 M | -69.8 M | -47.2 M | - | - | - | - | - | - |
Total Shareholders Equity |
371 M | 271 M | 346 M | 95.5 M | 93.2 M | -69.8 M | -47.2 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Bicycle Therapeutics plc
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
30.8 M | 30.7 M | 30.6 M | 30.5 M | 30.4 M | 30.3 M | 30.2 M | - | 30 M | 29.9 M | 29.8 M | 29.6 M | 29.5 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 1.25 M | 1.25 M | 1.25 M | 1.25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
191 M | 224 M | 223 M | 234 M | 186 M | 140 M | 128 M | - | 129 M | 134 M | 111 M | 84 M | 81.8 M | 65.7 M | 65.7 M | 65.7 M | 65.7 M | 17 M | 17 M | 17 M | 17 M | 29.3 M | 29.3 M | 29.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
16.4 M | 25 M | 27.2 M | 29.8 M | 25 M | 20.4 M | 16.4 M | - | 19.2 M | 19.3 M | 17.5 M | 8.74 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 728 K | 728 K | 728 K | 728 K | 10 K | 10 K | 10 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-538 M | -512 M | -463 M | -413 M | -370 M | -331 M | -301 M | - | -246 M | -218 M | -200 M | -186 M | -168 M | -152 M | -152 M | -152 M | -152 M | -101 M | -101 M | -101 M | -101 M | -69.9 M | -69.9 M | -69.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
547 M | 595 M | 639 M | 454 M | 429 M | 411 M | 417 M | - | 460 M | 480 M | 281 M | 226 M | 224 M | 161 M | 161 M | 161 M | 161 M | 110 M | 110 M | 110 M | 110 M | 81.6 M | 81.6 M | 81.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
457 M | 526 M | 572 M | 340 M | 294 M | 339 M | 361 M | 373 M | 407 M | 439 M | 260 M | 199 M | 196 M | - | - | - | - | - | - | - | - | - | 63.4 M | 63.4 M | - | 67.7 M | - | - | - | 9.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
356 M | 371 M | 416 M | 220 M | 243 M | 271 M | 289 M | - | 330 M | 346 M | 171 M | 142 M | 142 M | 95.5 M | 95.5 M | 95.5 M | 95.5 M | 93.2 M | 93.2 M | 93.2 M | 93.2 M | 52.4 M | 52.4 M | 52.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
356 M | 371 M | 416 M | 220 M | 243 M | 271 M | 289 M | 311 M | 330 M | 346 M | 171 M | 142 M | 142 M | 95.5 M | 95.5 M | 95.5 M | 95.5 M | 93.2 M | 93.2 M | 93.2 M | 93.2 M | -69.8 M | -69.8 M | -69.8 M | -47.7 M | -47.2 M | - | - | - | -33.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency